Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Egerton

Showing results (11-20 of 99) with videos related to

Pageof 10
Sort By:
Neuroimage|December 26, 2009
The test-retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic functionAlice Egerton, Arsime Demjaha, Philip McGuire, et al.
Frontiers in Psychiatry|May 16, 2017
Effects of Antipsychotic Administration on Brain Glutamate in Schizophrenia: A Systematic Review of Longitudinal <sup>1</sup>H-MRS StudiesAlice Egerton, Akarmi Bhachu, Kate Merritt, et al.
Synapse (New York, N.Y.)|January 19, 2007
Agonist-dependent internalization of D2 receptors: Imaging quantification by confocal microscopyJulian L Goggi, Alessandro Sardini, Alice Egerton, et al.
JAMA Psychiatry|June 16, 2016
Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy StudiesKate Merritt, Alice Egerton, Matthew J Kempton, et al.
Psychopharmacology|February 1, 2005
Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophreniaAlice Egerton, Lee Reid, Clare E McKerchar, et al.
Schizophrenia Research|October 19, 2020
Glutamate in schizophrenia: Neurodevelopmental perspectives and drug developmentAlice Egerton, Anthony A Grace, James Stone, et al.
Psychopharmacology|March 2, 2019
Altered glutamatergic response and functional connectivity in treatment resistant schizophrenia: the effect of riluzole and therapeutic implicationsToby Pillinger, Maria Rogdaki, Robert A McCutcheon, et al.
Frontiers in Psychiatry|August 11, 2018
Biological Predictors of Clozapine Response: A Systematic ReviewRuta Samanaite, Amy Gillespie, Kyra-Verena Sendt, et al.
Psychopharmacology|April 23, 2008
Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in ratsAlice Egerton, Lee Reid, Sandie McGregor, et al.
Addiction Biology|September 4, 2019
Adolescent-onset heavy cannabis use associated with significantly reduced glial but not neuronal markers and glutamate levels in the hippocampusGrace Blest-Hopley, Aisling O'Neill, Robin Wilson, et al.
Pageof 10

Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
Neuroimage|December 26, 2009
The test-retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic functionAlice Egerton, Arsime Demjaha, Philip McGuire, et al.
Frontiers in Psychiatry|May 16, 2017
Effects of Antipsychotic Administration on Brain Glutamate in Schizophrenia: A Systematic Review of Longitudinal <sup>1</sup>H-MRS StudiesAlice Egerton, Akarmi Bhachu, Kate Merritt, et al.
Synapse (New York, N.Y.)|January 19, 2007
Agonist-dependent internalization of D2 receptors: Imaging quantification by confocal microscopyJulian L Goggi, Alessandro Sardini, Alice Egerton, et al.
JAMA Psychiatry|June 16, 2016
Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy StudiesKate Merritt, Alice Egerton, Matthew J Kempton, et al.
Psychopharmacology|February 1, 2005
Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophreniaAlice Egerton, Lee Reid, Clare E McKerchar, et al.
Schizophrenia Research|October 19, 2020
Glutamate in schizophrenia: Neurodevelopmental perspectives and drug developmentAlice Egerton, Anthony A Grace, James Stone, et al.
Psychopharmacology|March 2, 2019
Altered glutamatergic response and functional connectivity in treatment resistant schizophrenia: the effect of riluzole and therapeutic implicationsToby Pillinger, Maria Rogdaki, Robert A McCutcheon, et al.
Frontiers in Psychiatry|August 11, 2018
Biological Predictors of Clozapine Response: A Systematic ReviewRuta Samanaite, Amy Gillespie, Kyra-Verena Sendt, et al.
Psychopharmacology|April 23, 2008
Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in ratsAlice Egerton, Lee Reid, Sandie McGregor, et al.
Addiction Biology|September 4, 2019
Adolescent-onset heavy cannabis use associated with significantly reduced glial but not neuronal markers and glutamate levels in the hippocampusGrace Blest-Hopley, Aisling O'Neill, Robin Wilson, et al.
Pageof 10